Clinical Trial Update: A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating gepotidacin versus ceftriaxone plus azithromycin for uncomplicated urogenital gonorrhea has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gonorrhea

Drugs mentioned

• Azithromycin (azithromycin)
• Gepotidacin (gepotidacin)
• ceftriaxone (ceftriaxone sodium)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Gonorrhea | Phase 3 | Status: COMPLETED | Results posted: 2024-05-30